Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Does insomnia kill?

Barbara Phillips1, David M Mannino

  • 1Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, University of Kentucky College of Medicine, Lexington, KY, USA. bphil95@aol.com

Sleep
|October 13, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chronic Airways Assessment Test: Performance and Health Predictors in the AlphaNet Population.

American journal of respiratory and critical care medicine·2026
Same author

Spirometry for assessing work ability and impairment: navigating Scylla and Charybdis.

American journal of respiratory and critical care medicine·2026
Same author

Frailty in middle adulthood and associations with negative health-related outcomes in NHANES.

Aging clinical and experimental research·2026
Same author

Disease modification and progression in pre-chronic obstructive pulmonary disease: an official American Thoracic Society workshop report.

Annals of the American Thoracic Society·2026
Same author

Severe Obesity and Alpha-1 Antitrypsin Deficiency-Associated COPD: A Dual Burden on Health and Quality of Life.

Chronic obstructive pulmonary diseases (Miami, Fla.)·2026
Same author

Addressing polymorbidity in chronic obstructive pulmonary disease: an opportunity to improve outcomes.

European journal of internal medicine·2025

Insomnia complaints affect 23% of middle-aged adults, but this study found no increased mortality risk from insomnia or hypnotic use over 6.3 years.

Area of Science:

  • Epidemiology
  • Sleep Medicine
  • Cardiovascular Disease Research

Background:

  • Insomnia is a common sleep complaint with potential health implications.
  • Understanding the prevalence and mortality risk associated with insomnia is crucial for public health.
  • The Atherosclerosis Risk in Communities Study provides a valuable cohort for investigating chronic disease risk factors.

Purpose of the Study:

  • To determine the prevalence of insomnia complaints in a large cohort of middle-aged adults.
  • To investigate the association between insomnia complaints and mortality risk.
  • To examine the impact of hypnotic medication use on mortality.

Main Methods:

  • Prospective cohort study involving 13,563 participants aged 45-69.
  • Multivariate regression analysis was used to identify predictors of insomnia.

Related Experiment Videos

  • Hazard ratios for death were calculated, controlling for various covariates.

    • Main Results:

    • The prevalence of insomnia complaints was 23% in the study cohort.
    • Key predictors of insomnia included female sex, lower income, younger age, depressive symptoms, heart disease, and respiratory issues.
    • Insomnia complaints and hypnotic use were not significantly associated with increased mortality risk over 6.3 years.

    Conclusions:

    • Insomnia complaints are prevalent in middle-aged adults.
    • Neither insomnia complaints nor the use of hypnotic medications predicted increased mortality in this cohort after adjusting for confounders.